First Trust Health Care AlphaDEX Fund (NYSEARCA:FXH – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 25,260 shares, a growth of 74.3% from the August 31st total of 14,491 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 81,084 shares, the short-interest ratio is presently 0.3 days.
Institutional Trading of First Trust Health Care AlphaDEX Fund
A number of institutional investors and hedge funds have recently made changes to their positions in FXH. Envestnet Asset Management Inc. lifted its stake in First Trust Health Care AlphaDEX Fund by 59.8% during the second quarter. Envestnet Asset Management Inc. now owns 94,077 shares of the company’s stock worth $11,515,000 after purchasing an additional 35,197 shares during the last quarter. Royal Bank of Canada increased its position in First Trust Health Care AlphaDEX Fund by 19.4% during the 1st quarter. Royal Bank of Canada now owns 78,075 shares of the company’s stock worth $8,570,000 after purchasing an additional 12,680 shares in the last quarter. Perryman Financial Advisory Inc. AD bought a new position in First Trust Health Care AlphaDEX Fund in the 4th quarter valued at approximately $8,277,000. Waverly Advisors LLC boosted its position in First Trust Health Care AlphaDEX Fund by 4.6% in the second quarter. Waverly Advisors LLC now owns 30,159 shares of the company’s stock valued at $3,692,000 after buying an additional 1,323 shares in the last quarter. Finally, PCG Wealth Advisors LLC grew its stake in shares of First Trust Health Care AlphaDEX Fund by 88.9% during the second quarter. PCG Wealth Advisors LLC now owns 25,948 shares of the company’s stock worth $3,176,000 after buying an additional 12,213 shares during the last quarter.
First Trust Health Care AlphaDEX Fund Price Performance
First Trust Health Care AlphaDEX Fund stock traded down $1.64 during midday trading on Thursday, hitting $129.10. The company’s stock had a trading volume of 51,907 shares, compared to its average volume of 37,638. First Trust Health Care AlphaDEX Fund has a 1-year low of $104.53 and a 1-year high of $135.82. The company has a 50-day moving average price of $131.06 and a two-hundred day moving average price of $120.79. The company has a market cap of $1.13 billion, a price-to-earnings ratio of 16.75 and a beta of 0.73.
First Trust Health Care AlphaDEX Fund Company Profile
The First Trust Health Care AlphaDEX Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant Health Care Index. The StrataQuant Health Care Index is an index developed, maintained and sponsored by the NYSE Group, Inc or its affiliates (NYSE), which employs the AlphaDEX stock selection methodology to select stocks from the Russell 1000 Index.
See Also
- Five stocks we like better than First Trust Health Care AlphaDEX Fund
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Appleās $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for First Trust Health Care AlphaDEX Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Health Care AlphaDEX Fund and related companies with MarketBeat.com's FREE daily email newsletter.
